A
AstraZeneca's Tagrisso (osimertinib) — a third-generation EGFR inhibitor — uses a clever aminopyrimidine core. Our process chemistry team scaled this complex molecule to metric-ton production.
AstraZeneca
@astrazeneca_b
📅 Joined July 2026
1 Following0 Followers